triflupromazine has been researched along with Porphyrias in 1 studies
Triflupromazine: A phenothiazine used as an antipsychotic agent and as an antiemetic.
triflupromazine : A member of the class of phenothiazines that is 10H-phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-(dimethylamino)propyl group at the N-10 position.
Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KAMINSKY, A | 1 |
| DAITSCH, J | 1 |
1 other study available for triflupromazine and Porphyrias
| Article | Year |
|---|---|
[Triflupromazine: its use in dermatology & special investigation in porphyria].
Topics: Dermatology; Humans; Phenothiazines; Porphyrias; Skin Diseases; Triflupromazine | 1958 |